β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)

@article{Bartus20162AdrenoceptorAA,
  title={β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)},
  author={R. Bartus and Alexandre B{\'e}tourn{\'e} and A. Basile and Bethany L Peterson and J. Glass and N. Boulis},
  journal={Neurobiology of Disease},
  year={2016},
  volume={85},
  pages={11-24}
}
  • R. Bartus, Alexandre Bétourné, +3 authors N. Boulis
  • Published 2016
  • Medicine
  • Neurobiology of Disease
  • Amyotrophic lateral sclerosis (ALS) is a chronic and progressive neuromuscular disease for which no cure exists and better treatment options are desperately needed. We hypothesize that currently approved β2-adrenoceptor agonists may effectively treat the symptoms and possibly slow the progression of ALS. Although β2-agonists are primarily used to treat asthma, pharmacologic data from animal models of neuromuscular diseases suggest that these agents may have pharmacologic effects of benefit in… CONTINUE READING
    18 Citations
    Could Sirtuin Activities Modify ALS Onset and Progression?
    • B. Tang
    • Biology, Medicine
    • Cellular and Molecular Neurobiology
    • 2016
    • 12
    Neuromuscular junction degeneration in muscle wasting
    • 24
    β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure
    • 7
    • PDF
    &agr;‐Cedrene, a Newly Identified Ligand of MOR23, Increases Skeletal Muscle Mass and Strength
    • 7

    References

    SHOWING 1-10 OF 135 REFERENCES
    The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting.
    • 73
    • Highly Influential
    • PDF
    β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders.
    • 48
    A pilot trial with clenbuterol in amyotrophic lateral sclerosis
    • G. Sorarù, E. Pegoraro, +6 authors C. Angelini
    • Medicine
    • Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
    • 2006
    • 12
    Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.
    • 301
    • Highly Influential
    • PDF
    β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome
    • 50
    • PDF
    β2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis.
    • 16